Universe Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Universe Pharmaceuticals Inc inventory turnover ratio, the Universe Pharmaceuticals Inc's ability to sell and replace its inventory in the fourth quarter 2025, sequentially increased to 5.65 in the fourth quarter 2025, yet the ratio remained below the average, as UPC's market remain challenging.Average inventory processing period, for the Universe Pharmaceuticals Inc in Sep 30 2025 quarter, has decreased to 65 days, compare to 36500 days, in the 0 quarter.

Within Healthcare sector 66 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form in the third quarter 2025, to 729.

UPC Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Universe Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

UPC Inventory Turnover Ratio	(Sep 30 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Sep 30 2023) IV. Quarter
Y / Y Inventory Growth	92.13 %	4438210.2 %	65499.9 %	3044.52 %	34044.01 %
Y / Y Cost of Sales Growth	52449.66 %	-	-	-	20.5 %
Inventory Turnover Ratio (TTM)	5.65	-	-	-	0.07
UPC's Total Ranking	# 729	#	#	#	#
Average inventory processing period	65	-	-	-	5040
Seq. Inventory Growth	36.35 %	-26.66 %	0 %	92.13 %	3149716.51 %
Seq. Cost of Sales Growth	-	-	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 15
Healthcare Sector	# 67
Overall Market	# 729

Inventory Turnover Ratio Statistics
High	Average	Low
11.45	7.38	1.15
(Sep 30 2022)		(Sep 30 2023)

UPC Company Profile >> Back to UPC Efficiency Comparisons >> Compare UPC Inventory Turnover Ratio to its Competitors

Financial Statements
Universe Pharmaceuticals Inc's Inventories	$ 2,193 Millions	Visit UPC's Balance sheet
Universe Pharmaceuticals Inc's Cost of Revenues TTM	$ 11,558 Millions	Visit UPC's Income Statement
What are UPC's Sales?		Visit UPC's Sales by Segment

Other Inventory Turnover Ratios
Universe Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
UPC's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for UPC's Competitors
Inventory Turnover Ratio for UPC's Suppliers
Inventory Turnover Ratio for UPC's Customers

You may also want to know
UPC's Sales Growth Rates	UPC's Pe Price to earnings ratio	UPC's Receivables Turnover Ratio	UPC's Stock Quote
UPC's Net Income Growth Rates	UPC's Ps Price to Sales ratio	UPC's Sales per Employee	UPC's Asset Turnover Ratio
UPC's Net Margin	UPC's Pb Price to Book ratio	UPC's Financial Strength Ratios	UPC's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Sep 30 2025	Inventories at quarter ending Sep 30 2025
Natera Inc	14.32	$ 766.129 Millions	$ 54 Millions
Harvard Apparatus Regenerative Technology Inc	14.06	$ 0.622 Millions	$ 0 Millions
The Oncology Institute Inc	13.93	$ 198.545 Millions	$ 14 Millions
Aurinia Pharmaceuticals Inc	13.79	$ 29.418 Millions	$ 2 Millions
Rockwell Medical inc	13.30	$ 63.000 Millions	$ 5 Millions
Irhythm Holdings Inc	12.48	$ 207.000 Millions	$ 17 Millions
Option Care Health Inc	11.31	$ 4,459.129 Millions	$ 394 Millions
Cryo cell International Inc	10.70	$ 7.279 Millions	$ 1 Millions
Genedx Holdings Corp	10.56	$ 121.000 Millions	$ 11 Millions
Infusystem Holdings Inc	10.55	$ 62.977 Millions	$ 6 Millions
Lifemd Inc	10.28	$ 32.000 Millions	$ 3 Millions
Zevra Therapeutics Inc	9.32	$ 16.328 Millions	$ 2 Millions
Earth Science Tech Inc	9.30	$ 6.220 Millions	$ 1 Millions
Sotera Health Company	9.20	$ 506.000 Millions	$ 55 Millions
National Vision Holdings Inc	8.82	$ 793.761 Millions	$ 90 Millions
Lantheus Holdings Inc	8.82	$ 576.000 Millions	$ 65 Millions
Collegium Pharmaceutical Inc	8.66	$ 322.661 Millions	$ 37 Millions
Nutriband Inc	8.64	$ 1.515 Millions	$ 0 Millions
Castle Biosciences Inc	8.61	$ 68.896 Millions	$ 8 Millions
Aditxt Inc	8.52	$ 0.074 Millions	$ 0 Millions
Cardiff Lexington Corporation	8.39	$ 4.531 Millions	$ 1 Millions
Myriad Genetics Inc	8.35	$ 242.500 Millions	$ 29 Millions
Star Equity Holdings Inc	8.32	$ 67.222 Millions	$ 8 Millions
Novavax inc	8.19	$ 87.605 Millions	$ 11 Millions
Warby Parker Inc	8.16	$ 387.000 Millions	$ 47 Millions
Adaptive Biotechnologies Corporation	8.03	$ 71.180 Millions	$ 9 Millions
Semler Scientific inc	7.71	$ 3.413 Millions	$ 0 Millions
Opko Health Inc	7.70	$ 485.347 Millions	$ 63 Millions
Inogen Inc	7.63	$ 191.710 Millions	$ 25 Millions
Tarsus Pharmaceuticals Inc	7.57	$ 24.683 Millions	$ 3 Millions

Date modified: 2026-07-07T13:48:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.